Business Information
The group's principal activity is to focus primarily on the treatment of dermatological and podiatric conditions, and aesthetics medicine. The group has branded prescription products in a number of therapeutic categories, including acne, asthma, eczema, fungal infections, psoriasis, rosacea, seborrheic dermatitis and skin and skin-structure infections. Its products include the prescription brands restylane(R), dynacin(R), loprox(R), omnicef(R), plexion(R), triaz(R), lidex(R), and synalar(R), the over-the-counter brand esoterica(R) and buphenyl(R), a prescription product indicated in the treatment of urea cycle disorder. The products are sold primarily to pharmaceutical distributors and retail pharmacy chains. Customers include cardinal health inc, mckesson corp, quality king distributors and amerisourcebergen corp.
|
|
Name |
Title
|
Email
|
| Jonah Shacknai | Chmn., CEO | N/A | | Joseph Cooper | Exec. VP - Corporate, Product Development | N/A | | Mark Prygocki | Exec. VP, CFO, Corp. Sec., Treasurer | N/A | | Mitchell Wortzman | Chief Scientific Officer, Exec. VP | N/A | | Richard Havens | Exec. VP - Sales, Marketing | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 376,899 | 64,990 | | 2006 | 349,242 | (75,849) | | 2005 | 163,954 | 49,721
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
